| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |